Podcasts about medication adherence

In this episode of Product in Healthtech, we reconnect with Scott Martin, founder and CEO of Rescription, to discover how his company has evolved since our previous conversation.Topics covered:Rescription's "radical clarity" approach to transforming prescription drug costsHow Rescription leverages the 340B federal program as intended to benefit both health systems and patientsResults from partnerships with Bergen New Bridge and Baton Rouge General, showing 27-35% savingsWhy patients under Rescription's model receive zero-dollar copays for prescriptionsThe patent-pending adjudication technology developed with Vynyl that enables upfront processing at scaleRescription's ambitious expansion plans across 14 states and 15 additional health systemsKey moments:[01:16] Scott explains how Rescription's model differs from traditional PBMs[03:09] Clarifying misconceptions about the 340B program[05:14] Updates on partnerships with Bergen New Bridge and Baton Rouge General[07:25] How Rescription addresses pharmaceutical manufacturer pushback[09:24] Details on Rescription's patent-pending adjudication technology[11:15] Future expansion plans and new service offeringsResources mentioned:Wall Street Journal article featuring Rescription (link to be added)Follow Product in Healthtech:Website: productinhealthtech.comLinkedIn: Product in HealthtechEmail: info@productinhealthtech.com Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.

SecretBox aims to improve medication adherence and reduce misuse risks. In this episode, Adam Torres and Sofia Carvalho, Founder & CEO at SecretBox, explore Sofia's entrepreneurial journey and SecretBox. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

SecretBox aims to improve medication adherence and reduce misuse risks. In this episode, Adam Torres and Sofia Carvalho, Founder & CEO at SecretBox, explore Sofia's entrepreneurial journey and SecretBox. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

Michael chats with Kempton Presley, Chief Strategy Officer at AdhereHealth, LLC. In this episode, Michael and Kempton explore how advances in data analytics and behavioral science are transforming member engagement. They discuss how health plans and providers are leveraging predictive insights and omnichannel strategies to reach high-risk members by their preferred means. This personalized support, through incorporating science-backed techniques, helps address barriers to care and improve medication adherence. Kempton also shares insights on emerging trends in member engagement, the role of evidence-based interventions in shaping health outcomes, and what's next for the industry.

In this episode, Our guest is MARC RYAN, who has extensive leadership experience across the healthcare industry. Most recently, he was a founding executive and President of MedHOK (MHK, acquired by Hearst Health). He has launched and operated multiple health plans. Marc served in senior policy roles in state and federal government, including as state management secretary of Connecticut and helping build Medicare Part D's relationship with state drug assistance programs in 2006. He created Connecticut's Medicaid and children's health managed care programs and its long-term care continuum. Marc is the author of The Healthcare Labyrinth: A Guide To Navigating Health Plans and Fixing American Health Insurance and the host of the Healthcare Labyrinth Podcast.Topics covered:(1) What are the trends in drug spending and the impact on all types of insurance products -- Medicare, Medicaid, commercial/employer -- cost trends for medical and retail(2) What is driving the major increases in drug costs/spending?(3) How are GLP-1s treated across various products? And will coverage change?(4) American drug prices compared with others?  Can you discuss how we compare vs. other developed countries and why (more than twice -- in many cases 3, 4, and 5 times more -- impacts on employer, Medicare, etc. -- rising percentage of healthcare as well as employer) (5) Medicare drug price negotiations -- what it is and what has happened so far? where do you stand?(6) A lot is occurring in plans on PA, formularies, benefit design, PBM reform -- a very hot topic -can you tell us more about this and what you predict? (7) Can you explain the traditional PBMs vs. transparent ones? FTC lawsuit against PBMs and drug supply channel issues(8) There have been major changes to Part D and it is impacting Medicare Advantage and Part D -- what is happening for 2025 benefits as well as can you tell us a little on a study that questioned the value of Part D?(9a) Medication Adherence in the Star program for MA and Part D plans -- key.  Can you tell us more here? 9(b) How could pharmacists in the community support medication adherence etc -- Will discuss trends from health plans about recognizing the best way to ensure medication reconciliation and adherence is teaming up with pharmacists. Guest - Marc RyanHost - Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.comhttps://www.linkedin.com/in/hillary-blackburn-67a92421/ @talktoyourpharmacist for Instagram and Facebook ★ Support this podcast on Patreon ★

Send us a textArtificial intelligence is destined to play a big role in the pharmaceutical industry in 2025.With this rapid growth, what specific changes can we expect in patient support and pharmaceutical marketing?And how will that impact healthcare costs and patient experience?In this episode of the HealthBiz Podcast, guest William Grambley, CEO of AllazoHealth, discusses how artificial intelligence and patient-level data can lower operating costs, improve medication adherence, and create tailored solutions for patients at every stage of their journey.TOPICS(0:23) Intro(1:02) Background on William Grambley(2:34) How Naval Service Shaped William Grambley(3:23) The Role of Experience and Work History(6:38) What Brought William to AllazoHealth(9:05) Understanding Compliance, Persistence, and Adherence(10:36) Examining Low Levels of Adherence(12:28) How Issues with Medication Adherence Have Changed Over Time(15:00) Distinguishing Between Adherence and Therapy Initiation(17:32) The Importance of Personalization(20:35) The Future of Pharma and AI in 2025(25:02) Dynamic Change and Personalization(27:36) GLP-1s and Adherence(30:30) Book Recommendations from William Grambley

Michael Oleksiw is the CEO of Pleio, a company focused on addressing the emotional barriers to patient engagement and medication adherence that medical professionals often overlook. Emotional barriers like loneliness, fear, and stigma can impact patients of all ages and backgrounds when they are facing a health challenge. Pleio uses technology and a peer-to-patient model to personalize interactions with empathetic humans, provide ongoing patient support, track emotional patterns, and bring pharmacists in to work with patients taking multiple medications or with chronic conditions.   Michael explains, "Our focus on the emotional barriers is meant to complement what's out there today. The bulk of the focus when it comes to engaging patients and supporting patients is really on supporting the transaction, ensuring that a patient can get their medication, that they can get it cost-effectively, that they can pick it up, that it gets into their hands. But once they're at home, everything gets real really fast and they're faced with a variety of emotions such as loneliness, stigma, fear, etc. The American Medical Association recognizes that five of the eight major barriers to adherence are emotional, as I mentioned. So we try to stay in that swim lane and connect with the patient to target those barriers as a complement to all the stuff already being done out there." "You can say that we break White Coat syndrome in that we get the patient to focus on what's important to them. Many times, patients don't know or are intimidated by their healthcare professionals and don't know how to engage in conversation. So one of the things we do is instill confidence so they can engage in fruitful conversations with their pharmacists and the like. So, the best way to think of it is we're an extension of the pharmacy. We bring that trust and the care in the pharmacy into the home with what we call a peer-to-patient model where patients engage in conversation with people just like them to complement the baseline they received at the pharmacy." "Technology helps us be more efficient in terms of the patients we target, the words we choose, and the times we call. So, our view on technology is we use technology to support human interaction and make it better, optimize it, and make it more efficient, but not replace it. So, we don't use technology to pretend to be human. Humans do a good job at that. I think humans could own being human. Technology is meant to support the human to be more efficient, make things more personalized, and take that step back to see the big picture and address trends over time." #Pleio #MedicationAdherence #PatientEngagement #EmotionalBarriers #MedAI #DigitalHealth pleio.com Download the transcript here

Michael Oleksiw is the CEO of Pleio, a company focused on addressing the emotional barriers to patient engagement and medication adherence that medical professionals often overlook. Emotional barriers like loneliness, fear, and stigma can impact patients of all ages and backgrounds when they are facing a health challenge. Pleio uses technology and a peer-to-patient model to personalize interactions with empathetic humans, provide ongoing patient support, track emotional patterns, and bring pharmacists in to work with patients taking multiple medications or with chronic conditions.   Michael explains, "Our focus on the emotional barriers is meant to complement what's out there today. The bulk of the focus when it comes to engaging patients and supporting patients is really on supporting the transaction, ensuring that a patient can get their medication, that they can get it cost-effectively, that they can pick it up, that it gets into their hands. But once they're at home, everything gets real really fast and they're faced with a variety of emotions such as loneliness, stigma, fear, etc. The American Medical Association recognizes that five of the eight major barriers to adherence are emotional, as I mentioned. So we try to stay in that swim lane and connect with the patient to target those barriers as a complement to all the stuff already being done out there." "You can say that we break White Coat syndrome in that we get the patient to focus on what's important to them. Many times, patients don't know or are intimidated by their healthcare professionals and don't know how to engage in conversation. So one of the things we do is instill confidence so they can engage in fruitful conversations with their pharmacists and the like. So, the best way to think of it is we're an extension of the pharmacy. We bring that trust and the care in the pharmacy into the home with what we call a peer-to-patient model where patients engage in conversation with people just like them to complement the baseline they received at the pharmacy." "Technology helps us be more efficient in terms of the patients we target, the words we choose, and the times we call. So, our view on technology is we use technology to support human interaction and make it better, optimize it, and make it more efficient, but not replace it. So, we don't use technology to pretend to be human. Humans do a good job at that. I think humans could own being human. Technology is meant to support the human to be more efficient, make things more personalized, and take that step back to see the big picture and address trends over time." #Pleio #MedicationAdherence #PatientEngagement #EmotionalBarriers #MedAI #DigitalHealth pleio.com Listen to the podcast here

Send us a textMichael Demurjian is CEO And Chairman of Aspargo Labs ( https://aspargolabs.com/ ), which he co-founded in 2019, which is a distinguished pharmaceutical and med-tech company committed to developing innovative oral spray formulations and drug delivery systems.Mr. Demurjian brings extensive experience across finance, manufacturing, sales & marketing, logistics, and general management. He has experience in taking companies public, raising funds in public and private markets with both retail and institutional investors. Prior to Aspargo Labs, Mr. Demurjian served as COO, CFO and member of the Board of Directors of Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have tolerable toxicity profiles. At Tyme, Mr. Demurjian was instrumental in raising over 50 million dollars and obtaining a public listing on NASDAQ. He also served as CEO of Luminant Biosciences, an oncology research company studying metabolic pathways to destroying cancer cells.Throughout his career, Mr. Demurjian has successfully completed strategic transactions with G.E., Stryker, Black & Decker Corp., and Crane Cams. Mr. Demurjian currently sits on the Board of Directors of the Susan G. Komen Foundation, the NYU board of advisors and has served in the past on the Board of Directors of Luminant Bio., Mikronite Tech & KCC. #Aspargo #MichaelDemurjian #DrugFormulation #PatientCompliance #LiquidOralSuspensions #Bioavailability #Pharmacokinetics #Pharamcodynamics #Pharmacology #Adherence #Sildenafil #Dimenhydrante #Statins #Metformin #PotassiumIodide #Antiemetics #Dysphagia #MeteredDose #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Medication adherence is not just a transaction; it's a journey! In this episode, Michael Oleksiw, CEO of Pleio Inc., discusses the complexities of medication adherence and how his company addresses emotional barriers that prevent patients from taking their prescribed medications. He emphasizes the importance of understanding the patient journey and the role of pharmacies and pharma companies in supporting adherence. Michael shares insights on the impact of their interventions, the diverse client base they serve, and the lessons learned from setbacks in the industry. He concludes with advice for leaders on maintaining focus and the importance of collaboration in healthcare innovation. Tune in to highlight the complexities of medication adherence and the importance of understanding the patient journey! Resources: Connect with and follow Michael Oleksiw on LinkedIn. Follow Pleio Inc. on LinkedIn. Reach out to Michael at Michael@Pleio.com

October 23, 2024: Weston Blakeslee, VP of Population Health at DrFirst, to explore the intersection of medication management, population health, and artificial intelligence. Can medication adherence be improved through predictive models and smart technologies like pill bottle caps? Blakeslee explains DrFirst's role in bridging the gap between hospital visits and medication adherence, tackling long-standing data quality issues, and exploring innovative solutions in population health. Key Points:02:08 Medication Adherence and Population Health08:34 Innovative Solutions for Medication Tracking10:18 AI in Medication Management12:16 Future of Population HealthSubscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Those living with dementia - and their caregivers - will very likely encounter a time when adherence to prescribed medications becomes a challenge.Perhaps it's remembering what to take when, if a medication has actually been taken, or if it's actually working.Ali Hamad with Battle Creek's Luxcare Pharmacy joins this episode of Creating Dementia Solutions to talk about how pharmacists can help - including with an innovation called the "blister pack". Episode ResourcesLuxcare PharmacyMiles for Memories websiteMiles for Memories technologySherii Sherban talks to Community Matters about MFM technologyMore Creating Dementia Solutions episodesABOUT MILES FOR MEMORIESMiles For Memories is a Calhoun County, Michigan organization created in 2013 to raise awareness and funds for Alzheimer's Disease. Later in 2014, the vision was expanded to include all types of dementia. MFM raises money each year through sponsorships, community events, and grants to gather funds to create local programming for both the person living with dementia and the caregiver. Along with local efforts, 20% of the funds to prevention-related dementia research. Miles for Memories is a committee of 70-plus volunteers and are always looking for more to get involved.

How often do we contemplate the ripple effect of taking our medications as prescribed, particularly for the senior community? In today's episode, we're talking all about medication adherence, a cornerstone of effective healthcare, especially for our senior population. My guest today is Dr. Sarah Almilli, an Advanced Clinical Pharmacist, Founder and CEO of ELAK Health Inc. Dr. Almilli's journey from Loma Linda University to her role in healthcare showcases her dedication to enhancing patient care. Her accolades, also include the esteemed 2024 40 under 40 Leadership Award. In this conversation with Dr. Almilli, we'll tackle various facets of medication adherence, from common challenges faced by older adults to innovative digital solutions that can streamline healthcare management. We'll discuss how caregivers can better support their loved ones and the importance of discerning credible information in the vast digital health landscape. Prepare to gain valuable insights and practical tips as we explore how to navigate the complexities of healthcare with Dr. Almilli, bringing us her empathy and expertise in the field.   Learn more at https://elakhealth.org/   Thank you to our sponsor Magic Mind. Recieve up to 48% off your first subscription or 20% off one time purchases with code NAVIGATINGTHEWORLD20 at checkout HERE: https://magicmind.com/navigatingtheworld     We are not medical professionals and are not providing any medical advice. If you have any medical questions, we recommend that you talk with a medical professional of your choice. willGather has taken care in selecting its speakers but the opinions of our speakers are theirs alone. Thank you for your continued interest in our podcasts. Please follow for updates, rate & review! For more information about our guest, podcast & sponsorship opportunities, visit www.willgatherpodcast.com    *This episode is brought to you by Gigi Betty co., a boutique gift shop raising awareness and funds for caregivers and care partners. Show now at www.gigibettyco.com. Use the special code WILLGATHER20 for 20% off your order- Just for our podcast listeners!      

In this episode, George Lau, MD, FRCP (Edin, Lond), FHKAM (Med), FHKCP, FAASLD, MBBS (HKU), and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Consequences to poor adherence to antiviral therapyStrategies to promote medication adherence (eg, patient education, setting up routines)The role of routine monitoring to prevent complications related to HBV such as hepatocellular carcinoma  Presenter: George Lau, MD, FRCP (Edin, Lond), FHKAM (Med), FHKCP, FAASLD, MBBS (HKU)Specialist in Gastroenterology & HepatologyChairman and Senior Consultant in Gastroenterology and HepatologyHumanity and Health Medical GroupHong Kong, ChinaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: https://bit.ly/49TuZ8UGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to another enlightening episode of "Ditch the Lab Coat," the podcast where we critically examine health issues through a lens of scientific skepticism and practical wisdom. I'm your host, Dr. Mark Bonta, and today, we have a special guest, Dr. Shawn Gill, a clinical pharmacist and founder of Deprescribed Solutions. Dr. Gill collaborates closely with physicians and patients to create detailed taper plans for safely coming off medications like SSRIs. In this episode, we dive deep into the challenges of convincing physicians to adopt evidence-based tapering approaches, the importance of individualized patient care, and the hazards of over-relying on medication for minor ailments. Dr. Gill shares his practical, sustainable mental health-boosting practices and underscores the need to consider lifestyle interventions over long-term pharmaceutical treatments.Listen in as we explore the complexities of medication therapy in both acute and community settings, debate the appropriateness of prescribing SSRIs, and discuss the collaborative interprofessional model in healthcare. We also touch on the systemic challenges within a fee-for-service infrastructure and the significance of managing patient expectations during the transition off medications.Join us for an insightful discussion on how we can evolve as healthcare providers and implement holistic, non-pharmacological approaches to improve patient care. And remember, this podcast is aimed at fostering thoughtful discussion and is not a substitute for professional medical advice or treatment. Enjoy the episode, and stay tuned for more in-depth conversations on "Ditch the Lab Coat"!06:43 Limited access to specialists leads to disjointed care.10:31 Concern about medication adherence and deprescribing motivation.14:21 Navigating healthcare challenges and career self-reflection.16:53 Intervening with young patients to prevent complications.18:58 Emphasizing patient goals and identifying severity of symptoms.23:43 Antidepressant numbness, fear of stopping medication.26:22 Mental health treatment lacking options due to time.31:36 Pharmacist navigates patient dynamics without prescribing authority.32:59 Experienced doctor focuses on patient's mental health.37:31 Coordinate deep prescribing with physicians, share updates.39:19 Building trust, giving feedback, and fragile egos.42:33 Consider stopping antidepressants, it's possible and rewarding.47:07 Discontinuing medication requires careful adjustment and support.51:46 Reflection on medical practice, calls for diverse guests.53:48 Mother's nursing work inspired son's medical career.

On episode 110 of PSQH: The Podcast, Dr. Juan Maldonado, a Texas-based family medicine specialist, talks about his efforts to track medication adherence.

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome back to "Ditch the Lab Coat," the podcast where we explore the fascinating world of health and medicine with a skeptical eye. I'm Dr. Mark Bonta and In today's episode, Dr. Kaplovitch dives deep into the different types of blood clots and the importance of personalized treatment. He explains that not all blood clots are created equal - some predominantly affect the veins, while others can travel to the lungs and become life-threatening. We discuss the various risk factors that can lead to blood clot formation, from genetic conditions to long plane rides, and Dr. Kaplovitch offers practical advice on managing this complex disorder.We also touch on the fascinating history behind some blood thinning medications, like warfarin, which was originally used as rat poison! Dr. Kaplovitch clarifies the distinctions between its toxic properties and medical use. Throughout our conversation, we emphasize the importance of transparently counseling patients about the risks and benefits of different treatments. Dr. Kaplovitch highlights the abundance of research in the field of thrombosis and how it informs the personalized approach he takes with his patients.So join us as we simplify these complex medical concepts and explore the latest advancements in blood clot prevention and treatment. As always, remember that this podcast is for informational purposes only and does not substitute for professional medical advice. Let's ditch the lab coat and dive in!04:24 Experienced medical student impresses with professionalism.09:02 Blood clots can travel to lungs, fatal.12:14 Prolonged sitting at desk may increase thrombosis risk.16:01 Minority with blood clots can improve naturally.18:45 Clot busters have significant risk of bleeding.20:59 Treatment options for preventing blood clot complications.25:39 Passion for vascular medicine, citing primary literature.29:26 Newer blood thinners may have advantages.31:37 Warfarin inhibits clotting by blocking vitamin K.36:09 Balancing blood thinness for health benefits is crucial.37:22 Maintain optimal blood thinness to prevent risks.42:22 Minor bleeding from gut might not require action.46:27 Consistent blood thinner use is crucial.50:05 Discussing evolving thrombosis practices, specifically genetic testing controversies.51:24 Testing for clotting disorders requires informed discussion.57:02 Advancements in personalized medicine revolutionize treatment.58:45 Hip hop slang reference and deep thrombosis.

In this episode our ever-curious hosts, Doctor Nigel and Professor Jonathan, dive deep into the ‘sunny side' of skin health, shedding light on the multifaceted impact sunlight has on your body. The Docs embark on a comprehensive discussion about the perils of ultraviolet (UV) radiation. With a particular focus on the alarming rise of skin cancer cases in the sun-drenched land of Australia, they highlight how the country's love affair with the sun has led to it being dubbed the "skin cancer capital of the world."How do sun rays affect the skin differently? The Docs delve into the nitty-gritty of UV radiation, explaining how UVA and UVB rays penetrate the skin, causing everything from red-hot sunburns to DNA damage. While a tan might make you look like a bronzed god or goddess, it is actually your skin crying out for help.What are the key components of the Australian "5 S's" campaign? The conversation takes a hopeful turn as they explore the effectiveness of various preventative measures. The Docs praise the Australian "Slip, Slop, Slap, Slide, and Seek" campaign, which encourages people to slip on a shirt, slop on sunscreen, slap on a hat, slide on sunglasses, and seek shade. They also give some sun-sational advice, discussing the importance of using broad-spectrum sunscreens with high SPF, reapplying sunscreen every two hours, and wearing protective clothing. The Docs then emphasise the critical importance of early detection in combating skin cancer. They share personal anecdotes about friends and family members who have undergone skin checks, some of whom discovered potentially dangerous lesions just in the nick of time. Professor Jonathan quips that while it might feel like a game of "spot the difference," regular skin checks can be lifesaving. The Docs stress the need for listeners to adopt sun protection strategies diligently and to perform regular skin checks. They advise seeking medical advice for any skin concerns, no matter how trivial they may seem, because when it comes to skin health, it's better to be safe than sorry. As they wrap up, they remind everyone that while the sun might be a star, your skin should be the real star of the show, deserving all the care and protection it can get.—--DISCLAIMER: The views and opinions expressed on Join the Docs are those of Dr. Nigel Guest, Jonathan Sackier and other people on our show. Be aware that Join the Docs is not intended to be medical advice, it is for information and entertainment purposes only - please, always take any health concerns to your doctor or other healthcare provider. We respect the privacy of patients and never identify individuals unless they have consented. We may change details, dates, place names and so on to protect privacy. Listening to Join the Docs, interacting on our social media, emailing or writing to us does not establish a doctor patient relationship.To Contact Us: For a deeper dive on this episode's issue, merchandise and exclusive content, head to www.jointhedocs.comFollow us on youtube.com/JoinTheDocs Follow us on instgram.com/JoinTheDocsFollow us on tiktok.com/JoinTheDocsFollow us on: facebok.com/JoinTheDocsFollow us on: x.com/JoinTheDocs

In this episode, Professor Jonathan Sackier and Doctor Nigel Guest dive headfirst into the labyrinthine world of medical mysteries, sharing stories of patients that leave them scratching their heads in amazement.The Docs sink their teeth into a case of porphyria, a rare genetic disorder that can make you feel like you're auditioning for a vampire movie. They recount the tale of a man who, under the light of the full moon, would experience excruciating abdominal pain and a skin sensitivity that made him hiss at the mere thought of sunlight. The Docs emphasise the importance of recognising such rare conditions, lest you mistake your patient for a creature of the night.Why do some patients think they can outsmart their doctors? The conversation takes a hilarious turn when they discuss a patient who attempted to score drugs by pretending to have every ailment in the medical textbook. Doctor Guest recounts the saga of a man who complained of back pain, headaches, and a vague condition that magically responded only to the strongest painkillers. Coincidence?  The doctors laugh about how the patient's Oscar-worthy performance fell apart when he couldn't remember which leg he was supposed to be limping on. They highlight the importance of a thorough medical history and a keen eye for inconsistencies, proving that sometimes, being a doctor is a bit like being Sherlock Holmes.What's the wildest psychiatric case you've ever encountered? Doctor Guest then regales listeners with some of his most memorable psychiatric cases. He talks about a patient with myxoedema madness, a condition that was successfully diagnosed thanks to Guest's watching history. But the pièce de résistance was the woman who was convinced she was a poached egg. Doctor Guest describes how she wouldn't sit on a chair unless it was a piece of toast on it! The doctors discuss the complexities of such diagnoses and the importance of empathy and creativity in treatment. Why is treating chronic conditions like schizophrenia so challenging? The episode takes a more serious tone as The Docs delve into the challenges of treating chronic conditions like schizophrenia. They discuss the case of a man who ended up believing that ‘Prince Philip was in a helicopter wielding a mind-extracting ray gun' - just a royal misunderstanding. The doctors explain how such conditions require a comprehensive approach, combining medication, therapy, and sometimes a bit of humour to build trust with patients.This episode is a rollercoaster of emotions, blending humour with the sobering realities of medical practice. It underscores the need for a holistic approach, continuous education, and a dash of creativity in the ever-evolving field of medicine. Let's all do our part to break the stigma and help 'prescribe' a better future!—--DISCLAIMER: The views and opinions expressed on Join the Docs are those of Dr. Nigel Guest, Jonathan Sackier and other people on our show. Be aware that Join the Docs is not intended to be medical advice, it is for information and entertainment purposes only - please, always take any health concerns to your doctor or other healthcare provider. We respect the privacy of patients and never identify individuals unless they have consented. We may change details, dates, place names and so on to protect privacy. Listening to Join the Docs, interacting on our social media, emailing or writing to us does not establish a doctor patient relationship.To Contact Us: For a deeper dive on this episode's issue, merchandise and exclusive content, head to www.jointhedocs.comFollow us on youtube.com/JoinTheDocs Follow us on instgram.com/JoinTheDocsFollow us on tiktok.com/JoinTheDocsFollow us on: facebok.com/JoinTheDocsFollow us on: x.com/JoinTheDocs

Dr. Ron Razmi discusses his book, AI Doctor: The Rise of Artificial Intelligence in Healthcare, which focuses on the applications of AI in various areas of healthcare. Ron talks about AI as a foundational technology that uses statistical methods to analyze data and understand its meaning. It can be applied to various areas, such as coding and documentation, and can create algorithms to analyze heartbeats and detect abnormal rhythms.   AI Use in Diagnostics In diagnostics, AI can be helpful in analyzing clean structured data, such as radiology files from CAT scans or MRIs. AI can be trained to identify bleeding or abnormalities on these scans, but it must be trained on specific abnormalities. Currently, AI excels in radiology due to the digitized and structured data, but it's not as effective in narrative formats. Ron states that AI's applications in healthcare are vast and deep, and while it's still in its early stages, it has the potential to revolutionize various sectors, including healthcare. AI Tools in Radiology and Triage AI is increasingly being used in various fields, including radiology, dermatology, and sound AI. In radiology, AI tools are helping radiologists identify potential issues that might have been missed in traditional workflows. There are applications that read CAT scans for bleeding and stroke in acute settings, allowing radiologists to quickly identify and treat stroke patients. This helps in regaining function and ensuring patient recovery. AI can also aid in triage, prioritizing tasks based on urgency.    AI in Dermatology In dermatology, AI applications can help diagnose skin lesions. Additionally, sonar technology can be used to monitor people's activity and detect falls. This passive data collection method allows AI to analyze the signals and take action, reducing the need for manual data entry and manual data input. This technology is particularly effective for elderly individuals who may not want to be monitored with cameras, as 50% of falls occur in the bathroom. This technology is particularly useful for those who prefer to stay home but still need constant monitoring, such as those in assisted or independent living facilities.    AI in Cardiology In cardiology, AI tools can help read EKGs, which are crucial for diagnosing heart conditions. Historically, algorithms have been used to read EKGs, but they were often basic and inaccurate. AI has shown great promise in finding abnormalities on single lead data collection, as it can discern the rhythm of an EKG from a live core or smartphone application. This field-based data collection could significantly reduce the simple analytic and downstream work needed by clinicians in the medical staff.    AI in Therapeutics AI takes action in therapeutics, such as providing assistance to patients with mental health issues. AI chatbots can interact with patients who need help and provide frontline assistance until they see a mental health professional. Generative AI has improved natural language processing capabilities, which has been a problem area for AI in healthcare due to the heavy use of medical jargon in doctor's notes. This will allow for more efficient interactions with healthcare consumers and better guidance in their care. However, there is still much work to be done in this promising area.   Technology and Medication Adherence in Healthcare The conversation turns to medication adherence, which is a significant problem in healthcare. Long-term studies show that people who have had a heart attack are more likely to stay compliant with their medications, with the refill rate for statins being the highest documented rate. However, most people do not follow their prescription advice. Technology is part of the solution to this problem. AI technology can potentially analyze data and interact with patients at the appropriate moment to ensure they are aware of the needs, issues, and dates of medication use or the lack of, which is crucial in healthcare.    How AI Helps Doctors AI applications in healthcare can help alleviate the burden of documentation work for physicians and nurses. One example is the use of AI in critical care settings, where doctors often spend time typing notes into the electronic health record, which can lead to missed information and negatively impact the quality of care. AI can also analyze conversations using natural language processing, which can identify the meaning of words and improve communication. For example, AI can listen to conversations and extract key elements that need to be documented, allowing doctors to focus on the patient and generate notes in their preferred format. AI can also perform downstream tasks, such as prescribing medication, making referrals, and creating prior authorization letters. This could save time for medical staff, preventing them from seeing more patients and making them less productive. Another use case could be for AI to assist nurses in creating notes for patients based on interaction with them, reducing the time spent documenting. This could make a significant difference in the quality of care and well-being since it allows medical professionals to focus on the patient instead of taking notes.    Evaluating AI Healthcare Applications Ron's book goes beyond cheerleading and emphasizes the business and clinical barriers to adoption. He talks about the importance of evaluating the business model of AI products or applications, considering the incentives of buyers and the potential for job loss or revenue reduction. As an investor, he suggests considering the pain points that AI could address, such as staff shortages and burnout, and how AI could help medical centers and pharmaceutical companies improve their clinical trials. Ron also discusses the importance of understanding the value proposition of AI products in medical settings. He shares his experience as an investor in the healthcare AI space, advising companies and funds on identifying great use cases and evaluating barriers. Ron recommends reading sources like healthcare AI digests, health tech news, and interviews with experts to stay informed about trends and the latest AI applications.    Timestamps: 04:00 AI applications in radiology and dermatology, including AI-assisted diagnosis and triage 10:54 Using AI to analyze passive data collection from sonar/radar in indoor environments for health monitoring, including fall detection and heart rate measurement  15:12 AI in healthcare, particularly in diagnostics and therapeutics 21:22 Using AI technology to improve medication adherence 26:40 AI applications in healthcare, including documentation assistance and quality of care 34:41 AI in healthcare, investment considerations, and product evaluation 39:44 AI in healthcare with a former doctor turned investor   Links: LinkedIn: https://www.linkedin.com/in/ronald-m-razmi-md-2b55b8/ The Book: AI Doctor: The Rise of Artificial Intelligence in Healthcare   Unleashed is produced by Umbrex, which has a mission of connecting independent management consultants with one another, creating opportunities for members to meet, build relationships, and share lessons learned. Learn more at www.umbrex.com.

Medication adherence is not just about getting medication into people's hands, it's about ensuring they take it correctly. In this episode, Sebastian Seiguer, CEO and co-founder of Scene Health, shares his journey from starting a coffee chain in Munich to transitioning into healthcare due to a desire for more meaningful work inspired by his family's medical background. He explains how Scene Health employs video technology and a care team to ensure patients take their medications correctly, initially targeting tuberculosis and addiction medications and now expanding to conditions like asthma, diabetes, and hypertension, showing positive outcomes and cost savings. Sebastian emphasizes the importance of focusing on health outcomes rather than just adherence metrics, highlighting the need for immediate results in healthcare. He also discusses the untapped potential of medication adherence as a daily opportunity for patient engagement and improved chronic condition management.  Tune in and learn how innovative solutions like Scene Health are revolutionizing medication adherence and improving healthcare outcomes! Resources:  Watch the entire interview here.  Connect with and follow Sebastian on LinkedIn here. Learn more about Scene Health on LinkedIn and their website. Learn more about the documentary featuring Paul Farmer here. Contact Scene Health's team via email at info@Scene.health.

In this episode, Stacey Wasserman, Chief Business Officer at Medisafe, discusses the impact of medication adherence on healthcare economics. 

www.YourHealth.orgwww.SCHomeRx.comwww.thedisruptedpodcast.comwww.experiencinghealthcare.com

There's a good reason Medicare triple-weights medication adherence as a performance measure. Prescriptions aren't effective if patients can't access them easily or take them routinely. One way VHAN's Care Management team supports network members is by helping their patients overcome barriers to filling prescriptions and managing complex medication regimens. In this episode, clinical pharmacist Danya Wilson and nurse practitioner Catherine McMullan discuss the transformative power of personalized patient medication strategies. We explore how a renewed focus on medication adherence can help VHAN members improve health care outcomes and costs, leading to better contract performance and greater financial incentives. 

Leaders from CareFirst, CareSource, UPMC Health Plan and Scene Health explore how proper medication adherence ensures a higher quality of life, improves health outcomes and reduces healthcare costs. Many health plans saw their overall Medicare Star Ratings drop this year due to one particular area – medication adherence. Our expert panel from top-rated plans shares innovative and actionable strategies for overcoming barriers to medication adherence.    Topics for discussion include: Reasons traditional approaches to medication adherence are not effective Best ways to speed up intervention with a personalized, member-centric approach Financial and ratings impacts of medication adherence measures   Confirmed Panelists Tom Manetti, Associate Vice President, Quality Products, CareSource Molly McGraw, PharmD, BCPS, Manager, Clinical Pharmacy, UPMC Health Plan Suzanne Moxham, Director, Quality, Accreditation, & Government Programs at CareFirst BlueCross BlueShield Sebastian Seiguer, CEO & Co-Founder, Scene Health   Bios: https://www.brightspotsinhealthcare.com/events/how-medication-adherence-can-be-much-more-than-medication-adherence/   Connect with us on social media: Facebook: facebook.com/brightspotshc Instagram: https://www.instagram.com/brightspotshc/https://www.instagram.com/brightspotshc/ LinkedIn: https://www.linkedin.com/company/shared-purpose-connect/ Twitter: https://twitter.com/BrightSpotsinHChttps://twitter.com/BrightSpotsinHC TikTok: https://www.tiktok.com/@brightspotshchttps://www.tiktok.com/@brightspotshc This episode is sponsored by Scene Health  Meet Scene Health, the medication engagement company that's taking on the colossal $500 billion problem of medication nonadherence. But here's the twist – they're doing it in a novel way by leveraging asynchronous video engagement.   Scene's model of care enhances the CDC-endorsed gold standard for ensuring medication adherence, Directly Observed Therapy. Their team of pharmacists, nurses, and health coaches engage with members via back-and-forth videos to build trust through person-to-person connections and empower every patient to take every dose of medication properly.   And they're not just all talk. Scene Health has been clinically validated in 20 peer-reviewed publications and is already teaming up with Medicaid and Medicare health plans, public health departments, and life science organizations to tackle a range of conditions, from diabetes & asthma to sickle cell disease.

The Quality Corner Show welcomes back Dr. Ben Urick, PharmD, PhD, Principal Health Outcomes Researcher at Prime Therapeutics and Adjunct Assistant Professor of Clinical Education at the UNC Eshelman School of Pharmacy, to talk about trends in medication adherence including creating value through medication adherence improvement.Urick reviews a bit of existing literature on medication adherence and then explores the relationship between health expenditures and medication adherence.  Other topics include social determinants of health and what disease states are currently popular for medication adherence research.Ben Urick Referenced Materials:PBMI National Conference Video with Managed Healthcare ExecutivePQS Quality Corner Show Season 1 Episode 30

In this episode,  our guest is Charles Gellman - a visionary leader and accomplished entrepreneur, currently serving as the CEO of HiDO Health, a cutting-edge healthcare technology company. With a deep passion for improving people's lives through innovation, Gellman has dedicated his career to revolutionizing the healthcare industry. The Journey in healthcare began with his early exposure to the challenges faced by patients and healthcare professionals. Inspired by the potential of technology to solve these issues, he pursued a Master's degree in Clinical Informatics, laying a solid foundation for his future endeavors.  After completing his education, Charles Gellman embarked on a series of successful ventures, focusing on developing innovative solutions to address the inefficiencies and gaps in the healthcare system. His entrepreneurial spirit and relentless pursuit of excellence led to the creation of several groundbreaking healthcare startups, each contributing to the advancement of patient care and operational efficiency.In 2018, Gellman co-founded HiDO Health with the mission of empowering patients and healthcare providers through the seamless integration of technology and healthcare services. Under his leadership, HiDO Health has emerged as a leading provider of AI Assisted Robotics, leveraging artificial intelligence, data analytics, and telehealth platforms to improve patient outcomes and transform healthcare delivery.  Gellman's visionary approach has enabled HiDO Health to forge strategic partnerships with prominent healthcare organizations, establishing the company as a trusted and influential player in the industry. His commitment to collaboration and innovation has fostered a culture of creativity and excellence within the organization, attracting top talent and driving groundbreaking advancements in healthcare technology.Beyond his role at HiDO Health, Gellman actively contributes to the healthcare community through his participation in industry conferences, speaking engagements, and advisory roles. His expertise in healthcare technology and his ability to anticipate emerging trends have positioned him as a sought-after thought leader, shaping the future of healthcare through his insights and guidance.  With his relentless drive for progress and his unwavering dedication to improving healthcare outcomes, Charles Gellman continues to lead HiDO Health on a path of innovation and transformation. Through his visionary leadership, he aims to empower individuals, enhance healthcare delivery, and create a healthier world for all.Main points to cover: 1). High cost of medications without provider/payer insights into patient behaviors 2). Challenges of labor shortages and strikes to patient care3). The high cost of doing the same thing over and over 4). The impact of AI pharmacy to the future of home care5). Discovering the blueprint of health with different cocktails of medications 6). What is the pharmacy of the future and how can pharmacists practice at the top of their license Guest - Charles GellmanHost - Hillary Blackburn, PharmD, MBA www.hillaryblackburn.com   https://www.linkedin.com/in/hillary-blackburn-67a92421/  @talktoyourpharmacist for Instagram and Facebook @HillBlackburn Twitter ★ Support this podcast on Patreon ★

Why has an important quality and financial element like medical adherence flown under the radar all these years? Professor William (Bill) Kelly from Taneja College of Pharmacy at USF, joins our host, Jim Jorgenson, to discuss why pharmacist interventions and medication adherence are crucial to patients' quality of life. In the episode, Bill dives into his most recent publication on adherence and gives us a sneak peek of his upcoming studies about quality and safety. Click Here to read Bill's publication  Contact Bill: wkelly@usf.edu  

  During each of the last 3 years more than 100,000 people have died from drug overdoses in the United States. During this same time period, there has been a significant increase in patients suffering from mental health conditions. Today in the US, nearly 50 million patients are prescribed medications for mental health conditions, and that number is growing. Many of these medications are scheduled drugs / controlled substances. Drug testing is a critical tool to help monitor medication adherence for patients taking these medications. Drug testing can help in establishing a baseline for patients and help identify medication use or non-use, detect use of illicit substances, and help to prevent potential drug-drug interactions and harmful poly-substance use. Today's Topics in Drug Testing podcast episode will cover: Overview of the status of mental health in the US and mental health medication prescribing The role of drug testing in helping to monitor medication adherence for mental health and other controlled medications as well as identify illicit substance use and potential, harmful drug-drug interactions Implementing a responsible drug monitoring protocol in your practice, including how to test, who to test, what drugs to test for, and what frequency to test You may download a PDF version of this presentation here >> To listen to other podcasts in our Topics in Drug Testing series, please visit QuestDrugTesting.com. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

The failure of patients to take their medications as prescribed costs the U.S. healthcare system more than $500 billion a year, not to mention the adverse health outcomes it causes. Today's Raise the Line guest, Sebastian Seiguer, co-founded and leads a company called Scene Health that is tackling this problem with a system that combines video technology, clinical coaching and validated interventions to improve medication adherence rates. Based on evidence gathered in multiple clinical trials, the Centers for Disease Control recently concluded that using asynchronous video is equivalent to an in-person Directly Observed Therapy - the current gold standard for adherence. “It's an incredible thing. It's the first time in healthcare that an asynchronous video appointment is being treated the same as an in-person appointment,” Seiguer tells host Shiv Gaglani. Scene Health is currently supporting patients across multiple chronic and infectious conditions, including diabetes, asthma, opioid use disorder, tuberculosis and hypertension. Check out this enlightening conversation to learn why adherence is so low in the first place, how Scene Health is educating patients on how and why their medications work, and other applications for this approach.Mentioned in this episode: https://www.scene.health/

The Ups and Downs of Medication Adherence - Episode 134 - Transcript - In this episode of the Can Do MS podcast, we host CenterWell Specialty Pharmacy™ pharmacist Megan Winebrenner to discuss why it's important for people with MS to stick with their medications. Learn about the barriers that can prevent people from taking their medication as prescribed and what strategies and resources are available to help. Learn more about CenterWell and the role of the specialty pharmacy in MS care by viewing these resources: CenterWell Specialty Pharmacy The Role of the Specialty Pharmacy As Part of Your Healthcare Team – Videos   Disclaimer:  This program provides general educational information.  Can Do MS does not endorse, promote, or recommend CenterWell Specialty Pharmacy or any product or service associated with the content of this program. All product names, logos, brands and trademarks are property of their respective owners, and any use does not imply endorsement.

When Deepak Thomas contracted Lyme disease in his twenties, he quickly discovered how difficult it can be for a person to navigate the healthcare system, particularly when filling prescriptions. “When it came to accessing medications that could keep me healthy and eventually kick this condition, I found myself making three to four trips to the pharmacy every week, despite being covered by a generous healthcare plan.” So, by drawing on many years of experience working for leading tech companies such as Oracle and eBay, Thomas co-founded Phil, which offers a platform designed to remove provider and patient barriers to starting and continuing prescriptions. It's an important problem to tackle because 50% of treatment failures and 25% of hospitalizations in the U.S. can be attributed to people failing to take their medicines. Thomas says a differentiating feature of Phil's system is it works with the electronic health record or prior authorization programs the provider already uses while the automation runs behind the scenes. “The prescriber gets the benefits of automation without having to learn a new set of tools.” As for patients, they are sent a link -- often while still in the prescriber's office - which takes them through the process.  "The enrollment rates into the patient access programs offered by the manufacturers are easily 90% on average across all of our programs." Check out this episode of Raise The Line with host Michael Carrese to learn about a new approach to solving a vexing problem in healthcare, and the other areas of pharma services Thomas wants to focus on next.Mentioned in this episode: https://phil.us/

We welcome Andrew Burns, the Chief Growth Officer of DrFirst. We dive into a discussion about Timely by DrFirst, a pioneering digital platform reshaping the medication adherence landscape. Currently reaching over 50 million patients and 220,000 providers, Timely's collective reach continues to grow rapidly. Andrew sheds light on how Timely, in partnership with life sciences brands, is enhancing the healthcare ecosystem by delivering crucial clinical and cost insights within the EHR. Furthermore, he outlines how Timely communicates personalized notifications regarding prescriptions, costs, and educational content on behalf of providers, fostering improved treatment adherence throughout a patient's healthcare journey. Join us on this exploration of Timely's disruptive breakthrough in the realm of pharma.

On episode 78 of PSQH: The Podcast, Olufunke Sokan, advanced practice pharmacist at the University of Maryland School of Pharmacy, talks about a recent study she conducted on medication adherence. This episode is presented by Drexel University as part of National Nurses Week.

Most people with epilepsy have difficulty always taking their medications as prescribed. How can clinicians and patients talk about the issue and find solutions? Sharp Waves spoke with Dr. Avani Modi and Dr. Desiree Williford, authors of a recent study on pediatric adherence in epilepsy.During the episode, Dr. Modi mentions online resources that can help individuals and families find ways to take medication as directed. These are available in English and Spanish on the Epilepsy Foundation website. The STAR trial (Supporting Treatment Adherence Regimens) was a randomized controlled trial. Results can be found at this link.  The International League Against Epilepsy invites you to explore the ILAE Academy: Interactive, practice based online courses for health care professionals who diagnose and treat epilepsy. Find more information at ilae-academy.org. Support the showSharp Waves episodes are meant for informational purposes only, and not as clinical or medical advice.The International League Against Epilepsy is the world's preeminent association of health professionals and scientists, working toward a world where no person's life is limited by epilepsy. Visit us on Facebook, Twitter, and Instagram.

Medication adherence remains an important yet vexing issue in American health care. According to the World Health Organization, medication adherence can have a more direct impact on patient outcomes than a specific treatment itself. Still, it is estimated that a staggering 50% of Americans don't take their chronic long-term therapy medications as prescribed. Statistics show that each year, poor adherence contributes to more than $500 billion in avoidable health care costs, around 125,000 potentially preventable deaths, and up to 25% of hospitalizations in the United States.  This issue of medication adherence is so important, yet so vexing to solve for because it is so multi-faceted and entrenched into the business economics of healthcare.  In this Race to Value, we must find a better way to ensure affordability and promote adherence to medication therapies.  This is a life or death situation – both from an economic and a clinical perspective.  If we don't find solutions to improve medication adherence as part of value-based care, patients will die.  And eventually, the weight of the entire healthcare system will collapse upon itself due to the unsustainable costs that are incurred due to avoidable healthcare utilization that medication adherence would have prevented! Our guest this week is Jason Rose, a leading expert on the trillion dollar impact of the medication adherence issues in our country and what can be done to address them. Since 2018, Jason Rose has been spearheading value-based care as CEO of AdhereHealth. The innovative technology company is focused on transforming healthcare by leveraging intelligent data analytics, promoting medication adherence and working with patients to resolve social determinants of health. Customers are managed care companies and employers looking to improve quality of care and reduce costs for their patients and employees, respectively. After one year in his role, AdhereHealth experienced its fastest-ever year of growth and has grown from about 100 employees to nearly 1,000 employees over the past three years.  This is a leader in the value-based care movement that you should be listening to, as medication adherence is one of the most critical challenges to overcome in the transformation of our industry.   Episode Bookmarks: 01:30 According to the World Health Organization, medication adherence can have a more direct impact on patient outcomes than a specific treatment itself. 01:45 50% of Americans don't take their chronic long-term therapy medications as prescribed. 02:00 Poor adherence contributes to more than $500 billion in avoidable health care costs, causes 125,000 potentially preventable deaths, and up to 25% of hospitalizations. 03:00 Introduction to Jason Rose, a leading expert on medication adherence and CEO ofAdhereHealth. 04:00 Support Race to  Value by subscribing to our weekly newsletter and leaving a review/rating on Apple Podcasts. 06:30 If unabated, medication non-adherence will soon be a trillion-dollar problem with no end in sight. 07:00 Jason discusses the financial impact of non-adherence and the criticality of addressing this issue in healthcare. 08:00 “Medication non-adherence should be one of the top issues in all of healthcare, given the size of the actual problem.” 08:30 How value-based care programs can improve adherence outcomes in both senior and commercial populations. 10:00 A series of factors, rather than a single one, determine patients' ability to follow treatment recommendations correctly. 11:00 Jason discusses the impact of social determinants of health (SDOH) on medication adherence. 12:00 How SDOH symbolize the “Maslow Hierarchy of Needs for Health Care” (e.g. safe drinking water, transportation, health literacy). 13:00 A critical decision point – paying for the food of a beloved pet instead of purchasing lifesaving medication! 14:00 Referencing Jason's recent AJMC article: “Medication Adherence is a Force Multiplier for Medicare...

Have you started a prescription and then stopped taking it before its completion? Have you missed a dose or treatment as per the instructions provided by your healthcare provider? You're definitely not alone. While it may not seem like a big deal to miss even one dose or one scheduled treatment, it could have very serious consequences. On this episode Carla Purcell, RN with the Nova Scotia Health Authority discusses why it's so important to take medication as prescribed and follow a treatment schedule, why some people experience side effects and how to manage them and more.

Shane Bishop, the Founder and Chief Pharmacy Officer of Custom Health, aims for true medication adherence by providing multiple drugs in multi-dose strips in a manner that strongly encourages patients to stick with their medication regimen. Pharmacists and clinicians communicating with patients on a regular basis using a digital device gain a better understanding of side effects and other reasons people are not taking their medicine.  A fully integrated medication management system makes an enormous difference in the quality of life, particularly for complex patients who require a wide variety of drugs. Shane elaborates, "Now, where we differentiate ourselves from others that are trying to accomplish the same type of thing to drive medication adherence through different packaging formats, we have a medication dispensing device that sits in a patient home where it drives medication adherence by beeping, whistling and flashing at the time of administration." "The patient touches the screen and out pops one of those multi-dose strip packages and relays that information live back to our pharmacies in our network, the pharmacies we own and operate, and our clinical pharmacist team where we have up to 500 clinical pharmacists at any given time to look at the data. We also drive patient-reported outcome data." "Our device also connects to the peripheral devices via Bluetooth connection. We can actually look at the vital information driven from glucometers, blood pressure monitors, and weight scales."  #CustomHealth #HealthCare #DigitalHealth #MedicationAdherence #Pharmacy #HomeBasedCare #Technology customhealth.com Download the transcript here

Shane Bishop, the Founder and Chief Pharmacy Officer of Custom Health, aims for true medication adherence by providing multiple drugs in multi-dose strips in a manner that strongly encourages patients to stick with their medication regimen. Pharmacists and clinicians communicating with patients on a regular basis using a digital device gain a better understanding of side effects and other reasons people are not taking their medicine.  A fully integrated medication management system makes an enormous difference in the quality of life, particularly for complex patients who require a wide variety of drugs. Shane elaborates, "Now, where we differentiate ourselves from others that are trying to accomplish the same type of thing to drive medication adherence through different packaging formats, we have a medication dispensing device that sits in a patient home where it drives medication adherence by beeping, whistling and flashing at the time of administration." "The patient touches the screen and out pops one of those multi-dose strip packages and relays that information live back to our pharmacies in our network, the pharmacies we own and operate, and our clinical pharmacist team where we have up to 500 clinical pharmacists at any given time to look at the data. We also drive patient-reported outcome data." "Our device also connects to the peripheral devices via Bluetooth connection. We can actually look at the vital information driven from glucometers, blood pressure monitors, and weight scales."  #CustomHealth #HealthCare #DigitalHealth #MedicationAdherence #Pharmacy #HomeBasedCare #Technology customhealth.com Listen to the podcast here

Dr. Adam Mendelsohn, the CEO of Vivani Medical, seeks to enable people to receive the maximum potential benefits from medicines while minimizing the associated burden with taking those medicines. Drug implants overcome forgetfulness, procrastination, and other human behavior that impacts medication adherence. They anticipate expanding partnerships with various drug molecules and indications around their nano portal drug delivery technology. Adam elaborates, "When these medicines are evaluated in randomized clinical trial settings, they produce fantastic results. But these results don't translate into the real world in the way that they possibly could, and the primary reason for this is, as Charles Everett Koop, former US Surgeon General, once said, "Drugs don't work in people that don't take them." So, we are aiming to address this by developing miniature subdermal implants that can provide steady therapeutic doses over many months, guaranteeing medication adherence for these patients and, hopefully, improving real-world outcomes for chronic diseases." "The underlying technology we've demonstrated works with peptide therapeutics and some of the larger protein-based therapeutics. These are larger hydrophilic molecules that some of the other implant technologies have not been shown to be compatible with. We do believe that the technology could work with smaller hydrophobic molecules as well." "Down the road, we anticipate developing a portfolio of drug implants that can address adherence across a wide range of chronic diseases. But we have been pretty focused on a few different peptides and one in particular that we are preparing to begin a phase II clinical study early next year with around the type 2 diabetes indication. But the underlying technology is a platform that we think does have broad applicability." #VivaniMedical #MedicationAdherence #DrugImplants #ChronicDiseases #Type2Diabetes Vivani.com Download the transcript here

Dr. Adam Mendelsohn, the CEO of Vivani Medical, seeks to enable people to receive the maximum potential benefits from medicines while minimizing the associated burden with taking those medicines. Drug implants overcome forgetfulness, procrastination, and other human behavior that impacts medication adherence. They anticipate expanding partnerships with various drug molecules and indications around their nano portal drug delivery technology. Adam elaborates, "When these medicines are evaluated in randomized clinical trial settings, they produce fantastic results. But these results don't translate into the real world in the way that they possibly could, and the primary reason for this is, as Charles Everett Koop, former US Surgeon General, once said, "Drugs don't work in people that don't take them." So, we are aiming to address this by developing miniature subdermal implants that can provide steady therapeutic doses over many months, guaranteeing medication adherence for these patients and, hopefully, improving real-world outcomes for chronic diseases." "The underlying technology we've demonstrated works with peptide therapeutics and some of the larger protein-based therapeutics. These are larger hydrophilic molecules that some of the other implant technologies have not been shown to be compatible with. We do believe that the technology could work with smaller hydrophobic molecules as well." "Down the road, we anticipate developing a portfolio of drug implants that can address adherence across a wide range of chronic diseases. But we have been pretty focused on a few different peptides and one in particular that we are preparing to begin a phase II clinical study early next year with around the type 2 diabetes indication. But the underlying technology is a platform that we think does have broad applicability." #VivaniMedical #MedicationAdherence #DrugImplants #ChronicDiseases #Type2Diabetes Vivani.com Listen to the podcast here

www.SCHouseCalls.comwww.HouseCallsGA.comwww.MainStreetPhysicians.comwww.SCHomeRx.comwww.thedisruptedpodcast.comwww.experiencinghealthcare.com

Chris O'Brien, CEO of AdhereTech, talks about medication adherence and how his company is taking a different approach to addressing the issue by using smart bottles and smart caps to help patients remember to take their medication. Click this link to the show notes, transcript, and resources: outcomesrocket.health

Autoimmunity Following COVID-19 Infection Dr. Akhil Sood discusses abstract 0795 at ACR22 Convergence. Abstract 0795: Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications Best of ACR22 in PsA: Day Three Dr. Rachel Tate discusses the best PsA content presented on day three (Monday) at ACR22 Convergence in Philadelphia, PA. Medication Adherence intervention in SLE Dr. Bella Mehta speaks with Dr. Kai Sun abstract 0063 at ACR22 Convergence in Philadelphia, PA. Abstract 0063: Implementability of a SLE Medication Adherence Intervention Peresolimab for RA: Phase 2a Results Dr. Jonathan Kay abstract L03 at ACR22 Convergence in Philadelphia. L03: A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis

When it comes to managing older adults with hepatitis B virus (HBV), what comorbidity, comedication, and adherence issues should be considered?Listen as Graham R. Foster, FRCP, PhD, discusses these considerations and more for strategizing the monitoring and treatment of older adults with HBV. Presenter: Graham R. Foster, FRCP, PhDProfessor of HepatologyThe Liver UnitConsultant HepatologistQueen Mary University of LondonLondon, United KingdomLink to full program:https://bit.ly/3fg9fwB

Commentary by Dr. Valentin Fuster

"Automation and technologies can enable adherence, but true change happens when physicians and pharmacists work together in collaborative teams to achieve common goals: Better managed chronic conditions, fewer complications, and improved experience for patients and physicians." Tony Willoughby is a health care executive. He shares his story and discusses his KevinMD article, "Automatic refill and 90-day fill programs don't improve medication adherence." Did you enjoy today's episode? Rate and review the show so more audiences can find The Podcast by KevinMD. Subscribe on your favorite podcast app to get notified when a new episode comes out. Click here to earn 1.0 AMA PRA Category 1 CME for this episode. Also available in Category 1 CME bundles. Powered by CMEfy - a seamless way for busy clinician learners to discover Internet Point-of-Care Learning opportunities that reward AMA PRA Category 1 Credit(s)™. Learn more at about.cmefy.com/cme-info

We believe that local independent community pharmacy has a much wider role to play in future home-care. Historically, pharmacists have not been included on home care teams, despite the fact that home care patients require more pharmacy care services and frequently experience medication errors. There's an opportunity for Community Pharmacies to deliver more in-home care services. LTC pharmacies are compensated for services which many community pharmacies provide to their home-bound patient base. The optimal service delivery model of community pharmacies and distribution of additional clinical care for home care is a prime opportunity.  Special thanks to our episode sponsor RxSafe, leaders in Medication Adherence packaging & partners of Independent Community Pharmacy.  Guests:  Ronna Hauser, PharmD SVP Policy & Pharmacy Affairs at NCPA Susan Rhodus, BS Pharm  Senior Vice President, Contracts and Advocacy at GeriMed Joe Williams, PharmD Owner at Brisson Drugs References:  https://ncpa.org/medical-home-mah  Learn more about your ad choices. Visit megaphone.fm/adchoices

Become a supporter of The Healthy Project!When a patient's cultural background and mistrust of the healthcare system collide, it creates a barrier to medication adherence."I always try to keep that spirit of advocacy on the forefront of whatever I'm doing."Chayla Morris is a Clinical Pharmacist and coordinator for Broadlawns Medical Center. She has a background in chronic disease state management and is passionate about patient advocacy. In the interview, they discuss medication adherence and some barriers to adherence. Some of these barriers include patients not understanding what they're taking or how they're supposed to take it, adverse effects of the medication, and social determinants of health such as cost, transportation, and language barriers.In this episode, you will learn the following:1. Medication adherence – why it's important and some of the barriers to achieving it.2. The role of culture in influencing medication adherence.3. The importance of education in helping patients understand their medications and why they need to take them.Resources:Learn More about the My City My Health Conference!My CIty My Health Conference 2022Other episodes you'll enjoy:The Pandemic of Physical InactivityWorkplace Wellness on Employee HealthTaking Action on Health DisparitiesConnect with me:Instagram: https://www.instagram.com/thehealthyproject.co/Facebook: https://www.facebook.com/thehealthyproject.coYouTube: https://www.youtube.com/channel/UCpPV68YUvIpo4q2-vvBK7PwTwitter: https://twitter.com/thehealthyprojLinkedIn: https://www.linkedin.com/company/71735963/admin/Website: https://thehealthyproject.co/Loved this episode? Leave us a review and rating here: Apple | SpotifySupport the show

The vast majority of adults who start ADHD medication stop taking it within a year. The reasons have to do with the nature of ADHD itself or the myths surrounding medication. William Dodson, M.D., offers strategies for consistent symptom management.